کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
1929065 | 1050443 | 2012 | 6 صفحه PDF | دانلود رایگان |
The extracellular senile plaques observed in Alzheimer’s disease (AD) patients are mainly composed of amyloid peptides produced from the β-amyloid precursor protein (βAPP) by β- and γ-secretases. A third non-amyloidogenic α-secretase activity performed by the disintegrins ADAM10 and ADAM17 occurs in the middle of the amyloid-β peptide Aβ and liberates the large sAPPα neuroprotective fragment. Since the activation of α-secretase recently emerged as a promising therapeutic approach to treat AD, the identification of natural compounds able to trigger this cleavage is highly required. Here we describe new curcumin-based modified compounds as α-secretase activators. We established that the aminoacid conjugates curcumin–isoleucine, curcumin–phenylalanine and curcumin–valine promote the constitutive α-secretase activity and increase ADAM10 immunoreactivity. Strickingly, experiments carried out under conditions mimicking the PKC/muscarinic receptor-regulated pathway display different patterns of activation by these compounds. Altogether, our data identified new lead natural compounds for the future development of powerful and stable α-secretase activators and established that some of these molecules are able to discriminate between the constitutive and regulated α-secretase pathways.
► The effect of new curcumin-based compounds on α-secretase activity is investigated.
► Curcumin amino-acids conjugates promote the hydrolysis of the α-secretase substrates JMV2770 and βAPP.
► These effects are accompanied by an increase in ADAM10 immunoreactivity.
► Curcumin and its derivatives differencially affect the constitutive and regulated α-secretase pathways.
Journal: Biochemical and Biophysical Research Communications - Volume 424, Issue 4, 10 August 2012, Pages 691–696